Peter Horanyi
Senior Principal Scientist UCB
Seminars
Wednesday 2nd December 2026
Chair’s Opening Remarks
8:40 am
Wednesday 2nd December 2026
Chair’s Closing Remarks
5:10 pm
Thursday 3rd December 2026
Chair’s Opening Remarks
8:50 am
Thursday 3rd December 2026
Panel Discussion: Beyond TfR1: Evaluating Next‑Generation BBB Receptors for Systemic Biologic Delivery to the Brain
9:00 am
- Which alternative BBB receptors (e.g. CD98hc, Ca4, ALPL, glycan and others) show the most promise beyond TfR1 for achieving sufficient brain uptake without compromising safety or peripheral PK?
- How can we optimize receptor affinity, valency, and trafficking profiles to balance efficient transcytosis with minimal lysosomal degradation or target-mediated clearance, as it pertains to payloads?
- Improving brain specific and cell specific targeting
- How should developers prioritize receptor selection based on modality (e.g. antibodies, enzymes, oligonucleotides) and indication-specific needs for brain distribution and cellular targeting?
Thursday 3rd December 2026
Panel Discussion: Direct vs Systemic Delivery: Driving Pharma Buy-In, Bottlenecks & Patient Perception
3:00 pm
- Compare direct CNS delivery and systemic administration in terms of tissue exposure and selectivity, and their impact on target-site concentration, dose, and efficacy–toxicity balance
- Evaluate translational challenges for direct delivery relative to systemic modalities, including device integration and demonstration of tissue-level pharmacological advantage
- Explore how patient, clinician, and commercial perspectives shape trade-offs between invasiveness and the potential for improved efficacy and reduced toxicity through targeted delivery
Thursday 3rd December 2026
Chair’s Closing Remarks
3:30 pm